
Opinion|Videos|August 30, 2024
Strategies to Manage Type 2 Inflammation in Respiratory Diseases
Author(s)Reynold A. Panettieri Jr, MD
A key opinion leader explores therapeutic approaches targeting inflammation to alleviate symptoms in COPD and asthma patients.
Advertisement
Episodes in this series

- How do these markers influence the treatment regimen for patients with asthma or COPD?
- How do comorbidities affect the management of type 2 inflammation in asthma and COPD?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
2
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
3
Value-Based Care Interventions and Management of CKD Progression
4
Defining the Role of Rilzabrutinib in ITP Management
5